Open-Label Extension Protocol to SNK01-AD01 Study

NCT07228078 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer Disease

Interventions

BIOLOGICAL: SNK01

Sponsor

NKGen Biotech, Inc.